These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8422337)

  • 1. Inhibition of copper-mediated oxidation of LDL by rat serosal mast cells. A novel cellular protective mechanism involving proteolysis of the substrate under oxidative stress.
    Lindstedt KA; Kokkonen JO; Kovanen PT
    Arterioscler Thromb; 1993 Jan; 13(1):23-32. PubMed ID: 8422337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolysis and fusion of low density lipoprotein particles independently strengthen their binding to exocytosed mast cell granules.
    Paananen K; Kovanen PT
    J Biol Chem; 1994 Jan; 269(3):2023-31. PubMed ID: 8294453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of macrophage-mediated low density lipoprotein oxidation by stimulated rat serosal mast cells.
    Lindstedt KA
    J Biol Chem; 1993 Apr; 268(11):7741-6. PubMed ID: 8463303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low density lipoprotein degradation by secretory granules of rat mast cells. Sequential degradation of apolipoprotein B by granule chymase and carboxypeptidase A.
    Kokkonen JO; Vartiainen M; Kovanen PT
    J Biol Chem; 1986 Dec; 261(34):16067-72. PubMed ID: 3536921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density-lipoprotein binding by mast-cell granules. Demonstration of binding of apolipoprotein B to heparin proteoglycan of exocytosed granules.
    Kokkonen JO; Kovanen PT
    Biochem J; 1987 Jan; 241(2):583-9. PubMed ID: 3593208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cell granule-mediated uptake of low density lipoproteins by macrophages: a novel carrier mechanism leading to the formation of foam cells.
    Kovanen PT
    Ann Med; 1991; 23(5):551-9. PubMed ID: 1756025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chymase bound to heparin is resistant to its natural inhibitors and capable of proteolyzing high density lipoproteins in aortic intimal fluid.
    Lindstedt L; Lee M; Kovanen PT
    Atherosclerosis; 2001 Mar; 155(1):87-97. PubMed ID: 11223430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low density lipoprotein degradation by rat mast cells. Demonstration of extracellular proteolysis caused by mast cell granules.
    Kokkonen JO; Kovanen PT
    J Biol Chem; 1985 Nov; 260(27):14756-63. PubMed ID: 3902839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteolytic enzymes of mast cell granules degrade low density lipoproteins and promote their granule-mediated uptake by macrophages in vitro.
    Kokkonen JO; Kovanen PT
    J Biol Chem; 1989 Jun; 264(18):10749-55. PubMed ID: 2659592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolism of low density lipoproteins by rat serosal mast cells.
    Kokkonen JO; Kovanen PT
    Eur Heart J; 1990 Aug; 11 Suppl E():134-46. PubMed ID: 2226522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble heparin proteoglycans released from stimulated mast cells induce uptake of low density lipoproteins by macrophages via scavenger receptor-mediated phagocytosis.
    Lindstedt KA; Kokkonen JO; Kovanen PT
    J Lipid Res; 1992 Jan; 33(1):65-75. PubMed ID: 1552234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cell-mediated inhibition of reverse cholesterol transport.
    Lee M; Lindstedt LK; Kovanen PT
    Arterioscler Thromb; 1992 Nov; 12(11):1329-35. PubMed ID: 1420092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of LDL in mast cells recovering from degranulation. Description of a novel intracellular pathway leading to proteolytic modification of the lipoprotein.
    Kokkonen JO; Lindstedt KA; Kovanen PT
    Arterioscler Thromb; 1993 Feb; 13(2):276-85. PubMed ID: 8427862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mast cell--a potential link between inflammation and cellular cholesterol deposition in atherogenesis.
    Kovanen PT
    Eur Heart J; 1993 Dec; 14 Suppl K():105-17. PubMed ID: 8131778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of rat mast cell protease 1 activity. Protease inhibition is prevented by heparin proteoglycan.
    Pejler G; Berg L
    Eur J Biochem; 1995 Oct; 233(1):192-9. PubMed ID: 7588746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of low density lipoproteins by secretory granules of rat serosal mast cells.
    Kovanen PT; Kokkonen JO
    J Biol Chem; 1991 Mar; 266(7):4430-6. PubMed ID: 1999427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid.
    Lindstedt L; Lee M; Castro GR; Fruchart JC; Kovanen PT
    J Clin Invest; 1996 May; 97(10):2174-82. PubMed ID: 8636396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of low density lipoproteins in stimulated rat serosal mast cells during recovery from degranulation.
    Kokkonen JO; Kovanen PT
    J Lipid Res; 1989 Sep; 30(9):1341-8. PubMed ID: 2480988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100.
    Fong LG; Parthasarathy S; Witztum JL; Steinberg D
    J Lipid Res; 1987 Dec; 28(12):1466-77. PubMed ID: 3323390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan.
    Gervasoni JE; Conrad DH; Hugli TE; Schwartz LB; Ruddy S
    J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.